Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01905865
Other study ID # 999913162
Secondary ID 13-HG-N162
Status Completed
Phase
First received
Last updated
Start date June 12, 2013

Study information

Verified date January 23, 2024
Source National Institutes of Health Clinical Center (CC)
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Background: - Parents of a child with an undiagnosed medical condition face a lot of uncertainty. They may not know how to take care of their child or how the illness will affect their family life. Researchers want to study how these parents cope with and adapt to their child s condition in light of this uncertainty. Being uncertain can make it hard for parents to adapt. But it also might give them hope. Researchers want to study how uncertain the parents think their situation is and how that affects the way they think they can cope. Personality traits, like being able to handle uncertainty and being resilient, might also affect coping. Objectives: - To understand how having a child with an undiagnosed illness affects the way their parents think they can cope. Eligibility: - Adults with a child who has a medical condition that has not been diagnosed for at least 2 years and involves at least 2 parts of the body. Design: - Participants will answer survey questions for about 30 minutes. The questions are about their thoughts and feelings about having a child with an undisclosed illness. - Participants can take the survey on paper or online.


Description:

The proposed study aims to test the effect of the degree of perceived uncertainty on coping efficacy among parents of children with undiagnosed medical conditions. There are many dimensions to uncertainty when there is no identified cause for a condition that affects one s child. They include illness identity, management, longevity and life planning, the meaning of the child s condition for the family and both the child s and the family s social connections. How parents of children with undiagnosed medical conditions appraise, cope and ultimately adapt to their child s condition in light of this uncertainty is largely unexplored. While high levels of perceived uncertainty may be seen as a threat to adaptation, there is evidence that parents find hope and opportunity in the uncertainty. The literature suggests that many factors affect how uncertainty is appraised, and higher levels of coping self-efficacy are associated with more effective coping and ultimately better adaptation. There is no research that systematically assesses the dimensions of uncertainty perceived by parents and whether overall perceptions of uncertainty or particular subsets are associated with coping efficacy. Further, personality traits, such as tolerance of uncertainty and resilience, may moderate these unexplored relationships. This study s conceptual framework is based on Lazarus and Folkman s Transactional Model of Stress and Coping and Mishel s Perceived Uncertainty in Illness Theory. A cross-sectional survey design will be used to quantitatively assess the relationships between dimensions of uncertainty and coping efficacy. Participants will be recruited through online support groups, website postings, and listservs. They will have the option of completing either a paper or online version of the survey.


Recruitment information / eligibility

Status Completed
Enrollment 168
Est. completion date
Est. primary completion date June 12, 2013
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility - Participants for this study will be English speaking men and women ages 18 years or older who have a child with an undiagnosed medical condition who have applied to the Undiagnosed Diseases Network, and have been assigned to the NIH. The participant may be the adoptive or biological parent. Parents may decide between themselves who will complete the survey as only one survey per household will be allowed.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States National Human Genome Research Institute (NHGRI), 9000 Rockville Pike Bethesda Maryland

Sponsors (2)

Lead Sponsor Collaborator
National Human Genome Research Institute (NHGRI) University of Virginia

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary A To assess the dimensions of perceived uncertainty and their relative importance among parents of children with undiagnosed medicalconditions. Enrollment
Primary B To assess the role of uncertainty in predicting coping efficacy among parents of children with undiagnosed medical conditions. Enrollment
Primary C To determine whether tolerance for uncertainty and optimism moderate the relationship between uncertainty and coping efficacy. Enrollment
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04703179 - Rare and Undiagnosed Disease Research Biorepository
Recruiting NCT04880356 - Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.
Recruiting NCT04586075 - UW Undiagnosed Genetic Diseases Program
Completed NCT01498263 - Inherited Diseases, Caregiving, and Social Networks
Recruiting NCT02927158 - Exome and Genome Analysis to Elucidate Genetic Etiologies and Population Characteristics in the Plain Community
Completed NCT03605004 - Adult Patients With Undiagnosed Conditions and Their Responses to Clinically Uncertain Results From Exome Sequencing